• Directly to main navigation
  • Directly to content

MDC Berlin Buch

  • 1:HomeI
  • 2:ContactI
  • 3:ImpressumI
  • 4:SitemapI
  • I
  • 5:DEUTSCH
MDC
Helmholtz Gemeinschaft

Main navigation

Main navigation:

  • 1:Research
  • 2:PhD / Education
  • 3:Events
  • 4:News
  • 5:Jobs
  • 6:About us
  • 7:ECRC
  • 8:BIMSB
  • 1:Research Teams
    • 1.1:Cardiovascular Molecular Genetics
      • 1.1.1:Activation of receptor
      • 1.1.2:Projects in Cardiovascular Molecular Genetics
        • 1.1.2.1:Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
        • 1.1.2.2:Dilated Cardiomyopathy (DCM)
        • 1.1.2.3:Left Ventricular Noncompaction (LVNC)
        • 1.1.2.4:Regeneration of the embryonic heart
        • 1.1.2.5:Congenital Heart Disease
        • 1.1.2.6:Nuclear Receptors as Potential Target for the Treatment and Prevention of Cardiovascular Disease
      • 1.1.3:Publications
      • 1.1.4:Team
      • 1.1.5:Group picture
      • 1.1.6:Contact
      • 1.1.7:In vivo Mouse Phenotyping Platform
  • 2:Research Areas
  • 3:Delbrück-Fellows
  • 4:Technology Platforms
  • 5:Research Grants
  • 6:Research Report
  • 7:Editorial Offices
  • 8:Rules of Good Scientific Practice

:


Home >  Research  >  Research Teams  >  Cardiovascular Molecular Genetics  >  Projects in Cardiovascular Molecular Genetics

Projects in Cardiovascular Molecular Genetics

 

Cardiomyopathies

  • Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
  • Dilated Cardiomyopathy (DCM)
  • Left Ventricular Noncompaction (LVNC)

 

Heart development and cardiac repair

  • Regeneration of the embryonic heart

 

Congenital Heart Disease

  • Family-based studies for the identification of genetic causes for congenital heart disease

 

Arteriosclerosis

  • Nuclear Receptors as Potential Target for the Treatment and Prevention of Cardiovascular Disease

 

  • 1: ContactI
  • 2: ImpressumI
  • 3:SitemapI
  • 4:SearchI
  • PrintI
  • 5:Deutsch
Advanced Search

  • Directly to main navigation
  • Directly to content